Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Biochemical Pharmacology
|
January 1, 1978
Inhibition of lymphocyte-mediated cytolysis by 2-fluoroadenosine--evidence for two discrete mechanisms of drug action
T P Zimmerman, G Wolberg, G S Duncan, et al.
The Journal of Experimental Medicine
|
August 10, 2000
Deficiency in the transcription factor interferon regulatory factor (IRF)-2 leads to severely compromised development of natural killer and T helper type 1 cells
M Lohoff, G S Duncan, D Ferrick, et al.
Immunity
|
October 8, 1999
TRAF2 deficiency results in hyperactivity of certain TNFR1 signals and impairment of CD40-mediated responses
L T Nguyen, G S Duncan, C Mirtsos, et al.
Cell
|
February 13, 2001
Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure
J Ruland, G S Duncan, A Elia, et al.
Biochemical Pharmacology
|
April 1, 1983
Inhibition of lymphocyte function by 9-deazaadenosine
T P Zimmerman, R D Deeprose, G Wolberg, et al.
Nuclear Medicine Communications
|
February 1, 1996
Imaging inflammation with 99Tcm-labeled chemotactic peptides: analogues with reduced neutropenia
A Pollak, A E Goodbody, J R Ballinger, et al.
Genes & Development
|
April 29, 1998
Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes
M Woo, R Hakem, M S Soengas, et al.
Nature Immunology
|
March 23, 2001
Brca1 required for T cell lineage development but not TCR loci rearrangement
T W Mak, A Hakem, J P McPherson, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 11, 1999
Genetic evidence for functional redundancy of Platelet/Endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions
G S Duncan, D P Andrew, H Takimoto, et al.
Cell
|
August 26, 1998
Differential requirement for caspase 9 in apoptotic pathways in vivo
R Hakem, A Hakem, G S Duncan, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Biochemical Pharmacology
|
January 1, 1978
Inhibition of lymphocyte-mediated cytolysis by 2-fluoroadenosine--evidence for two discrete mechanisms of drug action
T P Zimmerman, G Wolberg, G S Duncan, et al.
The Journal of Experimental Medicine
|
August 10, 2000
Deficiency in the transcription factor interferon regulatory factor (IRF)-2 leads to severely compromised development of natural killer and T helper type 1 cells
M Lohoff, G S Duncan, D Ferrick, et al.
Immunity
|
October 8, 1999
TRAF2 deficiency results in hyperactivity of certain TNFR1 signals and impairment of CD40-mediated responses
L T Nguyen, G S Duncan, C Mirtsos, et al.
Cell
|
February 13, 2001
Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure
J Ruland, G S Duncan, A Elia, et al.
Biochemical Pharmacology
|
April 1, 1983
Inhibition of lymphocyte function by 9-deazaadenosine
T P Zimmerman, R D Deeprose, G Wolberg, et al.
Nuclear Medicine Communications
|
February 1, 1996
Imaging inflammation with 99Tcm-labeled chemotactic peptides: analogues with reduced neutropenia
A Pollak, A E Goodbody, J R Ballinger, et al.
Genes & Development
|
April 29, 1998
Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes
M Woo, R Hakem, M S Soengas, et al.
Nature Immunology
|
March 23, 2001
Brca1 required for T cell lineage development but not TCR loci rearrangement
T W Mak, A Hakem, J P McPherson, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 11, 1999
Genetic evidence for functional redundancy of Platelet/Endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions
G S Duncan, D P Andrew, H Takimoto, et al.
Cell
|
August 26, 1998
Differential requirement for caspase 9 in apoptotic pathways in vivo
R Hakem, A Hakem, G S Duncan, et al.
Page
of 5